Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - ACCOUNTS PAYABLE
Accounts Payable ENTA - Enanta Pharmaceuticals, Inc.
8 M
LAST VALUE
15.48%
2 YEAR CAGR
3.65%
5 YEAR CAGR
15.62%
10 YEAR CAGR